Obesity Is a Brain Disease

In the U.S., 41.9% of adults are considered obese, with prevalence increasing from significantly in recent decades.1 What’s driving this public health epidemic is the burning question, with a wide range of factors, from ultraprocessed foods and linoleic acid to environmental chemicals, likely playing prominent roles. In a “60 Minutes” episode hosted by Lesley Stahl,2… Read More »

FDA Gives Accelerated Approval for Risky Alzheimer’s Pill

The U.S. Food and Drug Administration granted accelerated approval for the Alzheimer’s disease drug lecanemab (Leqembi). The drug, a monoclonal antibody, binds to amyloid beta in the brain. An 18-month study published in the New England Journal of Medicine1 found Leqembi reduced markers of amyloid in early Alzheimer’s disease and led to “moderately less decline”… Read More »

Upstream Outlines What is Next in Mobile Marketing in 2023

Martech specialist sets-up forward-thinking MNOs and Ecommerce brands for mobile marketing success Athens, London, Sao Paulo, 17 January 2023, – Upstream, the global mobile marketing technology specialist, is sharing its vision for the industry in 2023 as CMOs prioritise delivering personalized offers, exceptional customer experiences and targeted multichannel campaigns in the year ahead to support… Read More »